AIDIGONG (00286.HK): Trading Remains Suspended; 18-Month Delisting Deadline Expired and Extension Sought
NewTimeSpace News: On 20 August 2026, AIDIGONG MATERNAL & CHILD HEALTH LIMITED (00286.HK) published a quarterly update announcement under Rule 13.09, Rule 13.24A and Rule 13.49(6) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Despite the suspension of trading, the group continues to operate its business; given the limited cash balance, the company continues to explore opportunities to replenish its cash balance, although no viable fundraising opportunity had been identified as of the announcement date.
As of the announcement date, the company has not received any relevant financial information from its principal subsidiary Shenzhen AIDIGONG and is unable to determine a timetable for publishing its annual results and annual reports for the years ended 31 December 2024 and 2025. The independent forensic accountant, Grant Link Business Consulting Services Limited, has submitted a report on the forensic investigation to the independent board committee, which has been submitted to the Stock Exchange; the investigation faced significant obstacles as the investigation team could not access the business premises, operating systems or recent financial information of Shenzhen AIDIGONG. After reviewing the report, the board considers that it contains no findings previously undisclosed by the company.
On litigation, the case concerning the validity of the resolution and change of legal representative was heard at the Shenzhen Futian District People's Court on 23 March 2026, with no judgment rendered as of the announcement date; the Shenzhen Court of International Arbitration has ruled in favour of Guangdong Wanjia, and Ms. Zhu has applied to set aside the arbitral award, although neither the company nor Guangdong Wanjia has received any formal notice from any Chinese court. Following the removal of Mr. Zhu Peiqi and the resignations of Ms. Meng and Mr. Wang, the board comprises two executive directors and one independent non-executive director, falling below the minimum numbers required under Rules 3.10(1), 3.10A and 3.21; the company does not meet the single-gender board requirement under Rule 13.92(2), and is seeking suitable candidates to appoint new independent non-executive directors and fill the audit committee vacancy. The company recently noted, based on public information, that certain subsidiaries of Shenzhen AIDIGONG underwent equity structure changes between 24 July 2026 and 20 August 2026, which the board deeply regrets and which were never authorised by the company; legal experts have been engaged to assess the legality, validity and responsibilities of the relevant persons.
Under Rule 6.01A(1) of the Listing Rules, the Stock Exchange may delist any securities that have been suspended from trading for 18 consecutive months; the 18-month period for the company expired on 20 August 2026, and the company has applied to the Stock Exchange for an extension of the deadline, with no decision received as of the announcement date. Trading in the company's shares has been suspended since 9:54 a.m. on 21 February 2025 and will remain suspended until further notice.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
